Drug Trial Radar · NCT07440524
A Phase 2 Trial of JKN24011 in COPD
Last checked: Nov 19, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
215
Actual
Start
Aug 1, 2024
Primary completion
Apr 2, 2026
Study completion Apr 2, 2026
Sponsor
- Lead sponsor
- Joincare Pharmaceutical Group Industry Co., LtdIndustry
- Sponsor type
- Industry
- First posted
- Feb 27, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 40 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate the Efficacy and Safety of Subcutaneous JKN24011 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Conditions
- COPD (Chronic Obstructive Pulmonary Disease)
Interventions
JKN24011Biological
JKN24011 subcutaneous injection,Q4W
PlaceboOther
Placebo subcutaneous injection,Q4W
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annualised rate of moderate or severe COPD exacerbationsTime frame: Through the 52-week treatment period
- Annualised rate of moderate or severe COPD exacerbationsTime frame: Through the 28-week treatment period
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Huadong Hospital, Fudan University
Shanghai, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.